• Nenhum resultado encontrado

Non-alcoholic fat liver disease

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease.

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease.

... more liver fat content, and showed more reductions in blood glucose, triglycerides and cholesterol than the LSI group, which was con- cordant with those in previous studies ...hepatic fat, insulin ...

16

Effects of tin caulis dendrobium polysaccharide on the prevention of non-alcoholic fatty liver disease in rats

Effects of tin caulis dendrobium polysaccharide on the prevention of non-alcoholic fatty liver disease in rats

... fatty liver disease (NAFLD) has been a disturbing clinical ...common liver disease in China. Non-alcoholic fatty liver disease is closely related to ...that ...

5

Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)

Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)

... Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, which includes a spectrum of hepatic pathology such as simple steatosis, steatohepatitis, ...

5

Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model

Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model

... implicated in NASH pathogenesis and carcinogenesis, secondary to their role in pathways associated with cellular energy metabolism, free radical generation, and apoptosis (25-32). In NASH, mitochondrial dysfunction has ...

7

Apoptosis and miRNAs in non-alcoholic fatty liver disease pathogenesis

Apoptosis and miRNAs in non-alcoholic fatty liver disease pathogenesis

... the liver, SIRT1 promotes fatty acid oxidation and gluconeogenesis during nutrient deprivation via liver X receptor, peroxisome proliferator-activated receptor (PPAR) γ co-activator 1 α (PGC-1α), and ...

217

Metabolic pathway of non-alcoholic fatty liver disease: Network properties and robustness

Metabolic pathway of non-alcoholic fatty liver disease: Network properties and robustness

... fatty liver disease (NAFLD) is a pathological phenomenon caused by the accumulation of triglycerides (steatosis) and accompanied by or without necrotizing inflammation or ...a disease that under the ...

12

Effects of Ramadan fasting on plasma free fatty acids in patients with non-alcoholic fatty liver disease

Effects of Ramadan fasting on plasma free fatty acids in patients with non-alcoholic fatty liver disease

... In this regard, Muller et al. (1975) investigated the effect of fasting on the amount of liver fat and reported no increase in this index after fasting for 12 h. However, fasting for 36 h was found to ...

5

The Effect of Chlorella vulgaris Supplementation on Liver Enzymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease

The Effect of Chlorella vulgaris Supplementation on Liver Enzymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease

... There were no significant differences at baseline between the two groups in terms of age (37.00± 7.45 yr and 37.73±8.24 yr in intervention and placebo group, respective- ly), gender, marrital status, education level, ...

9

Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease

Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease

... of non-alcoholic fatty liver disease (NAFLD) is more common worldwide and no certain treatment apart from lifestyle modification has been established ...on non-alcoholic fatty ...

8

The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data

The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data

... of liver steatosis of study subjects were observed before enrolment and after 12 and 24 w of ...with liver fat contents between 5%-10% were considered to have ...

5

Bioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease.

Bioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease.

... triglycerides [30]. EHHADH binds to PPARa providing a positive feed-back loop, thereby adjusting the tissue expression levels of PPARa according to a given metabolic need [31]. In rats, down- regulation of ECHS1 has been ...

8

Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.

Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.

... ameliorating liver functions in different metabolic and physiological conditions ...high fat diet rodents ...reduce liver weight when intra-peritoneally admin- istered in ob/ob mice at 18 weeks of ...

17

Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.

Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.

... human liver and adipose tissue [26] and plays a role in the hydrolysis of three major glycerolipids ...In non-obese sub- jects, elevated ALT and TG levels, a higher degree of insulin resistance, increased ...

14

Estado nutricional e absorção intestinal de ferro em crianças com doença hepática crônica com e sem colestase

Estado nutricional e absorção intestinal de ferro em crianças com doença hepática crônica com e sem colestase

... chronic liver disease as characterized by the following anatomical and pathological findings in liver biopsy: fibrosis and nodularity, altered hepatic parenchyma structure and hepatic cell ...

8

Curcumin: Reintroduced Therapeutic Agent from Traditional Medicine for Alcoholic Liver Disease

Curcumin: Reintroduced Therapeutic Agent from Traditional Medicine for Alcoholic Liver Disease

... Curcumin-phosphatidylcholine (Lecithin) formulation is a patented product (Meriva®) that provides a better serum concentration of curcumin compared to free (unformulated) curcumin after oral administration (43). This ...

6

Arq. Bras. Oftalmol.  vol.70 número1

Arq. Bras. Oftalmol. vol.70 número1

... areas. The huge symmetrical enlargement impaired the vision due to closure of the eyes, and mid third of the face and the upper lip were also affected (Figure 1). The oral cavity, teeth and tongue showed no ...

3

Overlapping Clinical Features Between NAFLD and Metabolic Syndrome in Children

Overlapping Clinical Features Between NAFLD and Metabolic Syndrome in Children

... al. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine ...of liver damage in patients with ...

7

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus

... with non-alcoholic fatty liver disease, and treatment with rosiglitazone increased PON1 activity and reduced oxidative stress in both serum and ...

5

TABLE 1 Survival of NASH patients undergoing

TABLE 1 Survival of NASH patients undergoing

... of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American ...

8

J. Pediatr. (Rio J.)  vol.89 número4 en v89n4a15

J. Pediatr. (Rio J.) vol.89 número4 en v89n4a15

... Uric acid at normal plasma levels has been known to exert a neuroprotective effect, by acting as a free-radical scavenger; however, several observational studies have indi- cated that high levels of serum uric acid are ...

7

Show all 10000 documents...

temas relacionados